Scientists develop a novel and potent SARS-CoV-2 RBD-homodimer vaccine

By | September 13, 2021
A recent report published in the journal Cell Discovery has described the immunogenicity and protective efficacy of a novel coronavirus disease 2019 (COVID-19) subunit vaccine candidate. The vaccine induces robust immune responses in rodents and non-human primates and protects the animals against severe disease.